Evaluation of Serum Interleukin-33 Level in Iraqi Patients with and without Periodontal Disease

References

• Isola G, Pesce P, Polizzi A, Lo Giudice A, Cicciù M, Scannapieco FA. Effects of minimally invasive non-surgical therapy on C-reactive protein, lipoprotein-associated phospholipase A2, and clinical outcomes in periodontitis patients: a 1-year randomized, controlled clinical trial. J Periodontol. 2024;2024:1–14.
   Google Scholar
• Isola G, Polizzi A, Santonocito S, Alibrandi A, Pesce P, Kocher T. Effect of quadrantwise versus full-mouth subgingival instrumentation on clinical and microbiological parameters in periodontitis patients: a randomized clinical trial. J Periodont Res. 2024;1:1–10.
   Google Scholar
• Kayal RA. The role of osteoimmunology in periodontal disease. Biomed Res Int. 2013;12:1.
   Google Scholar
• Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol. 1997;14:112–143. doi:10.1111/j.1600-0757.1997.tb00194.x
   Google Scholar
• Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38:60–84. doi:10.1111/j.1600-051X.2010.01671.x
   PubMed Web of Science ®Google Scholar
• Da Luz FA, Oliveira AP, Borges D, Brígido PC, Silva MJ. The physiopathological role of IL-33: new highlights in bone biology and a proposed role in periodontal disease. Mediators Inflamm. 2014;2014:342410. doi:10.1155/2014/342410
   PubMed Web of Science ®Google Scholar
• Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE. IL 33 amplifies both Th1 and Th2 type responses through its activity on human basophils, allergen reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008;20:101930.
   Web of Science ®Google Scholar
• Tominaga SI, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Komatsu N. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem Biophys Res Commun. 1999;264:14–18. doi:10.1006/bbrc.1999.1469
   PubMed Web of Science ®Google Scholar
• Saidi S, Bouri F, Lencel P, et al. IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine. 2011;53:347–354. doi:10.1016/j.cyto.2010.11.021
   PubMed Web of Science ®Google Scholar
• Chapple IL, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri‐implant diseases and conditions. J Periodontol. 2018;89:S74–S84. doi:10.1002/JPER.17-0719
   PubMed Web of Science ®Google Scholar
• Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int. J Oral Sci. 2019;11:30. doi:10.1038/s41368-019-0064-z
   Web of Science ®Google Scholar
• Buduneli N, Ozcaka O, Nalbantsoy A. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J Periodontol. 2012;83:362–368. doi:10.1902/jop.2011.110239
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 2014;35:3–11. doi:10.1016/j.it.2013.09.001
   PubMed Web of Science ®Google Scholar
• Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585–1591. doi:10.1902/jop.2008.080183
   PubMed Web of Science ®Google Scholar
• Rodrigues WF, Miguel CB, Mendes NS, Oliveira CJF, Ueira-Vieira C. Association between pro-inflammatory cytokine interleukin-33 and periodontal disease in the elderly: a retrospective study. J Indian Soc Periodontol. 2017;21(1):4–9. doi:10.4103/jisp.jisp_178_17
   PubMedGoogle Scholar
• Hardman C, Ogg G. Interleukin-33, friend and foe in type-2 immune responses. Curr Opin Immunol. 2016;42:16–24. doi:10.1016/j.coi.2016.05.004
   PubMed Web of Science ®Google Scholar
• Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676–689. doi:10.1038/nri.2016.95
   PubMed Web of Science ®Google Scholar
• Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33–activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol. 2009;123(5):1047–1054. doi:10.1016/j.jaci.2009.02.026
   PubMed Web of Science ®Google Scholar
• Tada H, Matsuyama T, Nishioka T, et al. Porphyromonas gingivalis gingipain-dependently enhances IL-33 production in human gingival epithelial cells. PLoS One. 2016;11:e0152794. doi:10.1371/journal.pone.0152794
   PubMed Web of Science ®Google Scholar
• Tada H, Suzuki R, Nemoto E, et al. Increases in IL-33 production by fimbriae and lipopeptide from Porphyromonas gingivalis in mouse bone marrow-derived dendritic cells via Toll-like receptor 2. Biomed Res. 2017;38:189–195. doi:10.2220/biomedres.38.189
   PubMed Web of Science ®Google Scholar
• Köseoğlu S, Hatipoğlu M, Sağlam M, Ş E, Esen H. Interleukin‐33 could play an important role in the pathogenesis of periodontitis. J Periodontal Res. 2015;50:525–534. doi:10.1111/jre.12235
   PubMed Web of Science ®Google Scholar
• Malcolm J, Awang RA, Oliver-Bell J, et al. IL-33 exacerbates periodontal disease through induction of RANKL. J Dent Res. 2015;94:968–975. doi:10.1177/0022034515577815
   PubMed Web of Science ®Google Scholar
• Laperine O, Cloitre A, Caillon J, et al. Interleukin-33 and RANK-L interplay in the alveolar bone loss associated to periodontitis. PLoS One. 2016;11:e0168080. doi:10.1371/journal.pone.0168080
   PubMed Web of Science ®Google Scholar
• Kursunlu SF, Ozturk VO, Han B, Atmaca H, Emingil G. Gingival crevicular fluid interleukin-36beta (−1F8), interleukin-36gamma (−1F9) and interleukin-33 (−1F11) levels in different periodontal disease. Arch Oral Biol. 2015;60:77–83. doi:10.1016/j.archoralbio.2014.08.021
   PubMed Web of Science ®Google Scholar
• Habeeb SAK, Al-Kaabi SJM. Interleukin-33 level in biological fluids for periodontitis patients in AL-Najaf City, Iraq. Int J Drug Deliv Technol. 2021;11(3):706–710.
   Google Scholar
• Renjith A, Rajan NS, Shaila SN. Protein and mRNA expression of interleukin-33 in periodontally diseased and healthy individuals and impact of nonsurgical periodontal therapy in salivary IL-33 levels. J Indian Soc Periodontol. 2023;27:45–50. doi:10.4103/jisp.jisp_390_21
   PubMedGoogle Scholar
• Saglam M, Koseoglu S, Aral CA, Savran L, Pekbagriyanik T, Cetinkaya A. Increased levels of interleukin-33 in gingival crevicular fluids of patients with chronic periodontitis. Odontol. 2017;105:184–190. doi:10.1007/s10266-016-0259-0
   Google Scholar
• Askian R, Seifi S, Fereidoni M, Ghafori M, Nouri HR, Gholinia H. Salivary interleukin-33 level decreases following non-surgical periodontal treatment through scaling and root planning in moderate chronic periodontitis. J Dent Oral Disord. 2020;6(5):1145.
   Google Scholar